Cytokinetics Vs. Sarepta Therapeutics Industry Stock Comparison

Buy

56

CYTK
Cytokinetics

Last Price:

55.91

Seasonality Move:

-5.12%

Sell

37

SRPT
Sarepta Therapeutics

Last Price:

125.05

Seasonality Move:

0.19%

Buy

56

Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

The current Cytokinetics [CYTK] share price is $55.94. The Score for CYTK is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

37

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

The Cytokinetics share price today is $55.94
The current trend is relatively stagnant and CYTK is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $125.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

CYTK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.13	Sell
Relative Strength Index (14 RSI):	50.85	Buy
Chaikin Money Flow:	85136	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(54.84 - 56.98)	Buy
Bollinger Bands (100):	(52.22 - 60.12)	Sell

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.92	Sell
Relative Strength Index (14 RSI):	32.69	Sell
Chaikin Money Flow:	-233066	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(127.43 - 139.51)	Sell
Bollinger Bands (100):	(124.47 - 147.63)	Sell

CYTK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	55.31	Buy
20-day SMA:	55.75	Buy
50-day SMA:	56.23	Sell
200-day SMA:	62.7	Sell
8-day EMA:	55.64	Buy
20-day EMA:	55.66	Buy
50-day EMA:	56.04	Sell
200-day EMA:	56.46	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	126.01	Sell
20-day SMA:	132.96	Sell
50-day SMA:	138.54	Sell
200-day SMA:	126.19	Sell
8-day EMA:	126.73	Sell
20-day EMA:	130.78	Sell
50-day EMA:	134.9	Sell
200-day EMA:	128.87	Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Cytokinetics Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):